4 | ErbB Receptors (EGF Receptor)IBA
02/2011
-
07/2001 |
4 | Biological ProductsIBA
04/2007
-
12/2000 |
4 | Pharmaceutical PreparationsIBA
12/2001
-
12/2000 |
4 | Paclitaxel (Taxol)FDA LinkGeneric
08/2001
-
09/2000 |
4 | Fluorouracil (Carac)FDA LinkGeneric
05/2001
-
01/2000 |
3 | Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2011
-
07/2001 |
3 | Monoclonal AntibodiesIBA
02/2011
-
12/2004 |
3 | Proteins (Proteins, Gene)FDA Link
02/2006
-
12/2000 |
3 | Cytotoxins (Cytolysins)IBA
05/2003
-
01/2000 |
2 | Cetuximab (Erbitux)FDA Link
02/2011
-
01/2011 |
2 | DNA (Deoxyribonucleic Acid)IBA
01/2011
-
05/2003 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
02/2006
-
09/2000 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
08/2001
-
06/2001 |
2 | PlatinumIBA
02/2001
-
09/2000 |
2 | Antineoplastic Agents (Antineoplastics)IBA
01/2001
-
01/2000 |
2 | irofulvenIBA
12/2000
-
12/2000 |
2 | eniluracilIBA
10/2000
-
02/2000 |
1 | 3' Untranslated Regions (3' UTR)IBA
01/2011 |
1 | Formaldehyde (Formol)FDA Link
01/2011 |
1 | MicroRNAs (MicroRNA)IBA
01/2011 |
1 | ParaffinIBA
01/2011 |
1 | thiamine triphosphorate (TTP)IBA
04/2007 |
1 | Antisense OligonucleotidesIBA
02/2006 |
1 | Messenger RNA (mRNA)IBA
02/2006 |
1 | oblimersen (G3139)IBA
02/2006 |
1 | Antigen-Antibody Complex (Immune Complex)IBA
12/2004 |
1 | mAb-AR20.5IBA
12/2004 |
1 | AntigensIBA
12/2004 |
1 | bizelesinIBA
05/2003 |
1 | L 778,123IBA
12/2001 |
1 | TransferasesIBA
12/2001 |
1 | penclomedineIBA
09/2001 |
1 | Docetaxel (Taxotere)FDA Link
08/2001 |
1 | AnthracyclinesIBA
08/2001 |
1 | 4-phenylbutyric acid (Buphenyl)FDA Link
08/2001 |
1 | Folic Acid (Vitamin M)FDA LinkGeneric
07/2001 |
1 | 1843U89IBA
07/2001 |
1 | Thymidylate SynthaseIBA
07/2001 |
1 | Tyrosine Kinase InhibitorsIBA
07/2001 |
1 | Etoposide (VP 16)FDA LinkGeneric
06/2001 |
1 | becatecarin (XL 119)IBA
06/2001 |
1 | Capecitabine (Xeloda)FDA Link
05/2001 |
1 | 7-methylthiomethylpaclitaxel (BMS 184476)IBA
05/2001 |
1 | Thymidine PhosphorylaseIBA
05/2001 |
1 | A-Form DNA (A-DNA)IBA
02/2001 |
1 | taxaneIBA
02/2001 |
1 | furanIBA
01/2001 |
1 | Epoxy Compounds (Epoxides)IBA
01/2001 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2001 |
1 | 4-ipomeanolIBA
01/2001 |
1 | Mixed Function Oxygenases (Monooxygenases)IBA
01/2001 |
1 | MacrolidesIBA
12/2000 |
1 | EstersIBA
12/2000 |
1 | temsirolimusFDA Link
12/2000 |
1 | Sirolimus (Rapamycin)FDA Link
12/2000 |
1 | Immunosuppressive Agents (Immunosuppressants)IBA
12/2000 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
12/2000 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
12/2000 |
1 | GemcitabineFDA Link
12/2000 |
1 | vesnarinoneIBA
12/2000 |
1 | TabletsIBA
10/2000 |
1 | Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
10/2000 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2000 |
1 | Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2000 |
1 | Cytochrome P-450 CYP3AIBA
09/2000 |
1 | CamptothecinIBA
09/2000 |
1 | exatecan (DX 8951f)IBA
09/2000 |
1 | Folic Acid AntagonistsIBA
04/2000 |
1 | Pemetrexed (MTA)FDA Link
04/2000 |
1 | Vincristine (Oncovin)FDA LinkGeneric
03/2000 |
1 | rhizoxinIBA
03/2000 |